MBX Biosciences Balance Sheet Health
Financial Health criteria checks 5/6
MBX Biosciences has a total shareholder equity of $54.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $62.9M and $8.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$55.26m |
Equity | US$54.47m |
Total liabilities | US$8.41m |
Total assets | US$62.88m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MBX's short term assets ($58.8M) exceed its short term liabilities ($8.2M).
Long Term Liabilities: MBX's short term assets ($58.8M) exceed its long term liabilities ($212.0K).
Debt to Equity History and Analysis
Debt Level: MBX is debt free.
Reducing Debt: MBX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MBX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MBX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 36.5% each year